Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00751400 · ClinicalTrials.gov registry record · Phase 3
Naproxen Sodium Extended-Release Actual Use Study
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 497
- Enrollment target
NCT00751400 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 497 participants.
The verdict
NCT00751400, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 497 participants
- Enrollment target
Study Summary
The purpose of this Study is to assess how subjects will use the investigational product in an uncontrolled, naturalistic environment.
Interventions
- DRUG Naproxen Sodium ER (BAYH6689)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 497 participants |
| Start Date | 2008-07 |
| Est. Completion | 2008-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00751400
The ClinicalTrials.gov registry entry for NCT00751400 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 497 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Naproxen Sodium ER (BAYH6689) is the first listed.
NCT00751400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00751400 about?
NCT00751400 is a clinical study titled "Naproxen Sodium Extended-Release Actual Use Study". The purpose of this Study is to assess how subjects will use the investigational product in an uncontrolled, naturalistic environment.
What is the current status of trial NCT00751400?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 497 participants. The study started on 2008-07. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00751400?
The interventions under investigation include: Naproxen Sodium ER (BAYH6689) (DRUG).
Who is sponsoring clinical trial NCT00751400?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.